Complex PCI – In-stent Restenosis

Complex PCI – In-stent Restenosis


Philips, in collaboration with Radcliffe Cardiology, are pleased to present expert video cases filmed at the Royal Bournemouth Hospital, Bournemouth, UK. In these videos, Consultant Interventional Cardiologists Dr Peter O’Kane and Dr Jehangir Din perform two cases, incorporating iFR and IVUS, highlighting the challenges and practical approaches to complex PCI with in-stent restenosis. Additionally, the physicians demonstrate AngioSculpt, iFR co-registration, and the use of laser.

Case 1: LAD In-Stent Restenosis: iFR and IVUS Co-registration, laser atherectomy, final DCB and stenting

Case 2: CX in-stent restenosis: IVUS Co-registration, scoring balloon lesion-prep, IVUS-guided DCB treatment, SB branch rescue and final KBT

How to use AngioSculptX

How to do iFR Co-registration

How to use Laser

Interview – The importance of iFR and IVUS


Dr O’Kane was appointed as a consultant interventional cardiologist at the Royal Bournemouth Hospital in July 2007. This is currently the UK’s highest volume non-surgical PCI centre and he annually performs more than 450 PCI cases, including participation in a 24-hour primary PCI service. He is committed to teaching and education at many levels, from local fellowship training programmes to national and international proctorship on techniques and multiple adjunctive devices, such as rotational and laser atherectomy. He graduated from Charing Cross and Westminster Medical School in 1995 with a BSc in physiology with first class honours, a MBBS and many prizes, including the Llewelyn Prize for the second-best distinction in medical finals.

Dr Jehangir Din completed his undergraduate medical degree at the University of Edinburgh, together with a first class intercalated BSc honours degree. He undertook his cardiology training at Edinburgh Heart Centre, training in general cardiology and cardiac CT, and sub-specialising in percutaneous coronary intervention and stenting. He received a doctorate of medicine for his postgraduate research on the vascular and anti-inflammatory effects of omega 3 fatty acids in coronary heart disease.

Supported by: